SLRX   $2.0  8.11% Market Closed After Close 1.9201 -4.00%

Salarius Pharmaceuticals Inc

EMA (20): 2024-10-15 the price crossed up the moving average line and formed a short-term upside trend.

EMA (50): 2024-10-17 the price crossed up the moving average line and formed a short-term upside trend.

EMA (100): 2024-07-30 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and it crossed the zero line from the bottom. These factors mean that there is probably a growing trend. Last signal: up-crossing the middle level.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

Trend Type flat and down
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 34.21%
EMA (20) date of signal Oct. 15, 2024, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 10.27%
EMA (50) date of signal Oct. 17, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -38.83%
EMA (100) date of signal July 30, 2024, 3 a.m.
RSI Signals bullish
RSI (14) Yield 19.30%
RSI (14) date of signal Oct. 16, 2024, 3 a.m.
MACD Signals bullish
MACD Yield 0.0
MACD date of signal Oct. 18, 2024, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 0.0
Stochastic date of signal Oct. 18, 2024, 3 a.m.
Updated Oct. 18, 2024, 11:04 p.m.